Surmodics (SRDX) announced the successful early clinical use of its Pounce XL Thrombectomy System. The Pounce XL Thrombectomy System received FDA 510(k) clearance in September 2024, and is currently in limited market release, with full commercial launch planned following completion of the LMR.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SRDX: